Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 8 | 2014 | 197 | 1.300 |
Why?
|
| Spheroids, Cellular | 4 | 2014 | 40 | 0.690 |
Why?
|
| Fibroblasts | 8 | 2014 | 860 | 0.540 |
Why?
|
| Heart Valves | 3 | 2012 | 159 | 0.480 |
Why?
|
| Cell Fusion | 1 | 2010 | 23 | 0.430 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2011 | 231 | 0.410 |
Why?
|
| Blood Vessels | 1 | 2010 | 100 | 0.390 |
Why?
|
| Cell Adhesion Molecules | 2 | 2010 | 193 | 0.390 |
Why?
|
| Caveolin 1 | 4 | 2014 | 59 | 0.390 |
Why?
|
| Scleroderma, Systemic | 4 | 2014 | 432 | 0.380 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2014 | 101 | 0.370 |
Why?
|
| Heart | 3 | 2006 | 807 | 0.290 |
Why?
|
| Cell Differentiation | 9 | 2014 | 1017 | 0.290 |
Why?
|
| Printing, Three-Dimensional | 2 | 2014 | 30 | 0.270 |
Why?
|
| Coturnix | 1 | 2003 | 21 | 0.260 |
Why?
|
| Animals | 23 | 2014 | 20109 | 0.250 |
Why?
|
| Calcium-Binding Proteins | 1 | 2003 | 108 | 0.250 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 28 | 0.240 |
Why?
|
| Microfilament Proteins | 1 | 2003 | 103 | 0.240 |
Why?
|
| Lymphokines | 1 | 2002 | 52 | 0.240 |
Why?
|
| Embryonic Structures | 1 | 2002 | 2 | 0.240 |
Why?
|
| Rhombencephalon | 1 | 2002 | 9 | 0.240 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2002 | 35 | 0.240 |
Why?
|
| Growth Substances | 1 | 2002 | 75 | 0.240 |
Why?
|
| Elastin | 1 | 2003 | 113 | 0.230 |
Why?
|
| Ear, Inner | 1 | 2002 | 44 | 0.220 |
Why?
|
| Mice | 14 | 2014 | 8108 | 0.220 |
Why?
|
| Neovascularization, Physiologic | 1 | 2002 | 162 | 0.220 |
Why?
|
| Pulmonary Fibrosis | 2 | 2013 | 145 | 0.210 |
Why?
|
| Stem Cells | 3 | 2014 | 240 | 0.210 |
Why?
|
| Myocardium | 1 | 2006 | 1173 | 0.200 |
Why?
|
| Extracellular Matrix | 2 | 2012 | 478 | 0.200 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 370 | 0.190 |
Why?
|
| Monocytes | 3 | 2014 | 200 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 2671 | 0.180 |
Why?
|
| Proteins | 1 | 2002 | 489 | 0.170 |
Why?
|
| Alginates | 2 | 2014 | 36 | 0.170 |
Why?
|
| RNA, Messenger | 6 | 2013 | 1601 | 0.160 |
Why?
|
| Bleomycin | 2 | 2014 | 66 | 0.160 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2011 | 268 | 0.160 |
Why?
|
| Collagen Type I | 5 | 2012 | 173 | 0.150 |
Why?
|
| Cell Movement | 4 | 2014 | 611 | 0.150 |
Why?
|
| Cell Proliferation | 3 | 2014 | 1126 | 0.140 |
Why?
|
| Hyaluronan Receptors | 2 | 2013 | 141 | 0.140 |
Why?
|
| Ink | 1 | 2014 | 7 | 0.140 |
Why?
|
| Bioprinting | 1 | 2014 | 11 | 0.140 |
Why?
|
| Drug Delivery Systems | 2 | 2014 | 230 | 0.140 |
Why?
|
| Infusion Pumps | 1 | 2014 | 37 | 0.130 |
Why?
|
| Magnetic Phenomena | 1 | 2013 | 8 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 30 | 0.130 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 75 | 0.130 |
Why?
|
| Carbon Dioxide | 1 | 2013 | 78 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 126 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2014 | 215 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 185 | 0.120 |
Why?
|
| Chick Embryo | 4 | 2012 | 373 | 0.120 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 214 | 0.120 |
Why?
|
| Mesoderm | 2 | 2012 | 215 | 0.110 |
Why?
|
| Lung | 2 | 2013 | 806 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 3 | 2006 | 202 | 0.110 |
Why?
|
| Dermis | 1 | 2010 | 29 | 0.110 |
Why?
|
| Bioreactors | 2 | 2013 | 61 | 0.110 |
Why?
|
| Mice, Transgenic | 4 | 2011 | 1010 | 0.110 |
Why?
|
| Leukocytes | 1 | 2010 | 97 | 0.100 |
Why?
|
| Morphogenesis | 2 | 2008 | 160 | 0.100 |
Why?
|
| Robotics | 1 | 2010 | 50 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 186 | 0.100 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2008 | 15 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2014 | 269 | 0.090 |
Why?
|
| Genes, Homeobox | 1 | 2008 | 16 | 0.090 |
Why?
|
| Transplantation, Homologous | 2 | 2006 | 226 | 0.090 |
Why?
|
| Cells, Cultured | 5 | 2013 | 2597 | 0.090 |
Why?
|
| Humans | 18 | 2014 | 68792 | 0.090 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2008 | 24 | 0.090 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 141 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 2008 | 82 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2010 | 614 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 156 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 705 | 0.090 |
Why?
|
| Embryo, Nonmammalian | 2 | 2008 | 64 | 0.090 |
Why?
|
| Phenotype | 2 | 2011 | 917 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2008 | 140 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 85 | 0.080 |
Why?
|
| Glioma | 1 | 2008 | 137 | 0.080 |
Why?
|
| Fetal Heart | 1 | 2006 | 42 | 0.080 |
Why?
|
| Regenerative Medicine | 1 | 2006 | 16 | 0.080 |
Why?
|
| Hyaluronic Acid | 1 | 2008 | 207 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2013 | 2599 | 0.080 |
Why?
|
| Colony-Forming Units Assay | 1 | 2006 | 77 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2008 | 413 | 0.080 |
Why?
|
| Hematopoiesis | 1 | 2006 | 108 | 0.080 |
Why?
|
| Fibronectins | 2 | 2006 | 125 | 0.080 |
Why?
|
| Anatomy | 1 | 2006 | 37 | 0.080 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2006 | 36 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2006 | 95 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 329 | 0.070 |
Why?
|
| Organogenesis | 1 | 2005 | 49 | 0.070 |
Why?
|
| Hexuronic Acids | 2 | 2014 | 24 | 0.070 |
Why?
|
| Glucuronic Acid | 2 | 2014 | 25 | 0.070 |
Why?
|
| Aorta | 1 | 2006 | 307 | 0.070 |
Why?
|
| Receptors, CXCR4 | 2 | 2014 | 46 | 0.070 |
Why?
|
| African Americans | 1 | 2014 | 1898 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2006 | 392 | 0.060 |
Why?
|
| Fibrillins | 1 | 2003 | 25 | 0.060 |
Why?
|
| Actins | 3 | 2013 | 248 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 70 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2003 | 92 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2003 | 128 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2003 | 279 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2003 | 255 | 0.060 |
Why?
|
| Angiopoietin-2 | 1 | 2002 | 6 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 33 | 0.060 |
Why?
|
| Angiopoietin-1 | 1 | 2002 | 13 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2002 | 36 | 0.060 |
Why?
|
| Laminin | 1 | 2002 | 56 | 0.060 |
Why?
|
| Microinjections | 1 | 2002 | 115 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2002 | 99 | 0.060 |
Why?
|
| Integrins | 1 | 2002 | 117 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2003 | 198 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2002 | 216 | 0.050 |
Why?
|
| Antibodies | 1 | 2002 | 230 | 0.050 |
Why?
|
| Female | 8 | 2013 | 39962 | 0.050 |
Why?
|
| Endocardium | 2 | 2012 | 95 | 0.050 |
Why?
|
| Male | 7 | 2014 | 36233 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2006 | 1366 | 0.050 |
Why?
|
| In Vitro Techniques | 2 | 2014 | 728 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2013 | 478 | 0.050 |
Why?
|
| Whole-Body Irradiation | 2 | 2011 | 51 | 0.050 |
Why?
|
| Apoptosis | 1 | 2006 | 1613 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 1999 | 3221 | 0.050 |
Why?
|
| Biopsy | 1 | 1999 | 3573 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 1264 | 0.050 |
Why?
|
| Clinical Competence | 1 | 1999 | 3653 | 0.040 |
Why?
|
| Rats | 3 | 2013 | 5070 | 0.040 |
Why?
|
| Clone Cells | 2 | 2006 | 67 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 853 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 4510 | 0.040 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2014 | 16 | 0.030 |
Why?
|
| Osmosis | 1 | 2014 | 36 | 0.030 |
Why?
|
| Neoplasms | 1 | 2006 | 1586 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2014 | 83 | 0.030 |
Why?
|
| Apoferritins | 1 | 2013 | 6 | 0.030 |
Why?
|
| Hydrogels | 1 | 2014 | 46 | 0.030 |
Why?
|
| Horses | 1 | 2013 | 19 | 0.030 |
Why?
|
| Matrix Attachment Regions | 1 | 2013 | 4 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 181 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 61 | 0.030 |
Why?
|
| Magnetite Nanoparticles | 1 | 2013 | 24 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2013 | 37 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2013 | 32 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2013 | 38 | 0.030 |
Why?
|
| Culture Media | 1 | 2013 | 152 | 0.030 |
Why?
|
| Oxides | 1 | 2013 | 46 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2013 | 61 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 259 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 141 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 249 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 322 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2013 | 289 | 0.030 |
Why?
|
| Cattle | 1 | 2013 | 490 | 0.030 |
Why?
|
| Tricuspid Valve | 1 | 2012 | 42 | 0.030 |
Why?
|
| Endocardial Cushions | 1 | 2012 | 20 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 506 | 0.030 |
Why?
|
| AC133 Antigen | 1 | 2011 | 5 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2011 | 37 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2012 | 143 | 0.030 |
Why?
|
| Iron | 1 | 2013 | 195 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 375 | 0.030 |
Why?
|
| Oxygen | 1 | 2013 | 379 | 0.030 |
Why?
|
| Weight Loss | 1 | 2014 | 309 | 0.030 |
Why?
|
| Heart Valve Diseases | 1 | 2012 | 113 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2012 | 162 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2011 | 223 | 0.030 |
Why?
|
| Cell Survival | 1 | 2013 | 890 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 36 | 0.030 |
Why?
|
| Young Adult | 2 | 2013 | 5496 | 0.030 |
Why?
|
| Homeostasis | 1 | 2011 | 268 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2011 | 235 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 1718 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1488 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2012 | 361 | 0.020 |
Why?
|
| Quail | 1 | 2008 | 27 | 0.020 |
Why?
|
| Lac Operon | 1 | 2008 | 54 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2008 | 58 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 176 | 0.020 |
Why?
|
| Peptides | 1 | 2011 | 438 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 155 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1159 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 154 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 138 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 468 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 576 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2006 | 21 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 320 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2006 | 144 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 157 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 535 | 0.020 |
Why?
|
| Discoidin Domain Receptors | 1 | 2006 | 16 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2006 | 27 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 373 | 0.020 |
Why?
|
| Ligation | 1 | 2006 | 87 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1076 | 0.020 |
Why?
|
| Microcirculation | 1 | 2006 | 79 | 0.020 |
Why?
|
| Receptors, Mitogen | 1 | 2006 | 21 | 0.020 |
Why?
|
| Caspases | 1 | 2006 | 182 | 0.020 |
Why?
|
| Vimentin | 1 | 2006 | 45 | 0.020 |
Why?
|
| Species Specificity | 1 | 2006 | 296 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 164 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2006 | 84 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 226 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1436 | 0.020 |
Why?
|
| Perfusion | 1 | 2006 | 126 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2006 | 172 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 99 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2006 | 108 | 0.020 |
Why?
|
| Aged | 2 | 2013 | 14503 | 0.020 |
Why?
|
| Hypoxia | 1 | 2006 | 159 | 0.020 |
Why?
|
| Polymers | 1 | 2008 | 258 | 0.020 |
Why?
|
| Gestational Age | 1 | 2006 | 375 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 674 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1999 | 3217 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2005 | 207 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 3305 | 0.020 |
Why?
|
| Protein Binding | 1 | 2008 | 1000 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 493 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5494 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 3822 | 0.020 |
Why?
|
| Survival Rate | 1 | 1999 | 4060 | 0.020 |
Why?
|
| Middle Aged | 2 | 2013 | 20597 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2003 | 76 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 118 | 0.020 |
Why?
|
| Adult | 2 | 2013 | 20717 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2003 | 109 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 150 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 1977 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 428 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 4741 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2448 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 538 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 734 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 1792 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 2231 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 8641 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 1049 | 0.010 |
Why?
|
| United States | 1 | 2006 | 7025 | 0.010 |
Why?
|